Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液)

Min Deng; Xiang-qian Sui; Shi-bing Zhu; Wei Ma; Ying Xu; Zhi-ming Chen

doi:10.1007/s11655-010-0540-y

Your Location：

Home >

Browse articles >

Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液)

Updated：2021-08-27

- Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液)
- Chinese Journal of Integrative Medicine Vol. 16, Issue 5, Pages: 453-456(2010)
- Affiliations：
  
  Emergency Medicine Department, Integrated Chinese and Western Medicine Hospital, Zhejiang University of Traditional Chinese Medicine,Hangzhou,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-010-0540-y
  CLC：
- Published：2010，
  
  Published Online：25 September 2010，
Scan for full text
Deng, M., Sui, Xq., Zhu, Sb. et al. Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液)., Chin. J. Integr. Med. 16, 453–456 (2010). https://doi.org/10.1007/s11655-010-0540-y

Min Deng, Xiang-qian Sui, Shi-bing Zhu, et al. Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液). [J]. Chinese Journal of Integrative Medicine 16(5):453-456(2010)
Deng, M., Sui, Xq., Zhu, Sb. et al. Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液)., Chin. J. Integr. Med. 16, 453–456 (2010). https://doi.org/10.1007/s11655-010-0540-y DOI：

Min Deng, Xiang-qian Sui, Shi-bing Zhu, et al. Clinical observation on the treatment of atrial fibrillation with amiodarone combined with Shenmai Injection (参麦注射液). [J]. Chinese Journal of Integrative Medicine 16(5):453-456(2010) DOI： 10.1007/s11655-010-0540-y.

摘要

To observe the therapeutic efficacy and safety of amiodarone combined with Shenmai Injection (参麦注射液) on atrial fibrillation. A total of 351 patients with atrial fibrillation caused by cardiovascular diseases and idiopathic atrial fibrillation were assigned to amiodarone group (control group

128 cases) and amiodarone combined with Shenmai Injection group (treatment group

223 cases). The patients in the control group received intravenous injection of 150 mg amiodarone in 10 min

followed by intravenous drip infusion at 1 mg /min and 6 h later at 0.5 mg /min until 48 h or cardioversion. The patients in the treatment group received the same treatment of amiodarone

while in addition

they received an injection of Shenmai Injection of 100 mL simultaneously. Blood pressure

ventricular rate

and cardioversion were observed. The total efficiency rate was 98% (control group) and 99% (treatment group) (P>0.05). The mean ventricular rate decreased 23% and 31% in the control group and the treatment group

respectively (P<0.05). The mean cardioversion time of the two groups was 570±211 min and 351±123 min

respectively (P<0.05). Only mild side effects were observed in both groups. Compared with amiodarone

amiodarone combined with Shenmai Injection takes effect more quickly with low side effects on the treatment of atrial fibrillation.

Abstract

128 cases) and amiodarone combined with Shenmai Injection group (treatment group

223 cases). The patients in the control group received intravenous injection of 150 mg amiodarone in 10 min

followed by intravenous drip infusion at 1 mg /min and 6 h later at 0.5 mg /min until 48 h or cardioversion. The patients in the treatment group received the same treatment of amiodarone

while in addition

they received an injection of Shenmai Injection of 100 mL simultaneously. Blood pressure

ventricular rate

respectively (P<0.05). The mean cardioversion time of the two groups was 570±211 min and 351±123 min

respectively (P<0.05). Only mild side effects were observed in both groups. Compared with amiodarone

amiodarone combined with Shenmai Injection takes effect more quickly with low side effects on the treatment of atrial fibrillation.

关键词

Atrial FibrillationamiodaroneShenmai injection

Keywords

Atrial FibrillationamiodaroneShenmai injection

references

Vijayalakshmi K, Whittaker VJ, Sutton A, Campbell P, Wright RA, Hall JA, et al. A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. Am Heart J 2006;52:863–866.

Saksena S, Madan N. Hybrid therapy of atrial fibrillation: algorithms and outcome. J Interv Cardid Electrophysiol 2003;9:235–247.

ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:257–354.

Chen X. Clinical arrhythmology-electrophysiology and treatment. Beijing: People’s Medical Publishing House; 2000:780–789.

Cao KJ, Chen ML. Strengthen the comprehensive therapy of atrial fibrillation. Chin J Cardiol 2006;34:766–768.

Gotsman I, Zwas D, Planer D, Azaz-Livshits T, Admon D, Lotan C, et al. Clinical outcome of patients with heart failure and preserved left ventricular function. Am J Med 2008;121:997–1001.

Meng F, Yoshikawa, Baba A, Moritani K, Suzuki M, Satoh T, et al. Beta-blockers are effective in congestive heart failure patients with artrial fibrillation. J Card Fail 2003;9:398–403.

Tuseth V, Jaatun HJ, Dickstein K. Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment. Heart 2005;91:964–965.

Cybulski J, Kulakowski P, Budaj A, Danielewicz H, Maciejewicz J, Kawka-Urbanek T, et al. Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation. Clin Cardiol 2003;26:329–335.

Li YL. Clinical observation on the preventive effect of Shenmai Injection on arrhythmia induced by aconitine toxication. Acad Periodical Changchun Coll Tradit Chin Med (Chin) 2000;16(1):16.

Liu M. Shenmai Injection terminate supraventricular tachycardia of 2 cases. Chin J Inf Tradit Med (Chin) 1998;5(12):58.

Jia LW, Zhu SH. Observation of Shenmai Injection on ventricular late potential in patient with coronary atherosclerotic heart disease. Integr Tradit Chin West Med Pract Crit Care Med (Chin) 1998;5:40.

Li H, Cai H, Zhang FL. Analyzing sample of treatment on dilated cardiomyopathy complicated with atrial fibrillation by Shenmai Injection combined with metoprolol. J Pract Tradit Chin Intern Med (Chin) 2008:22(3):25–26.

Zhao RH. Observation of the therapeutic efficacy of Yiqi Huiyang Jiuyin method combined with large dose of dopamine and small dose of sodium nitroprusside on severe cardiogenic shock. Integr Tradit Chin West Med Pract Crit Care Med (Chin) 1999;6:375–376.

Zhang H, Yuan RY, Yang JH, Wang HM. The improvement of Shenmai Injection on the hypotension caused by acute myocardial infarction. Integr Tradit Chin West Med Pract Crit Care Med (Chin) 2004;11:253.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Shenmai Injection (参麦注射液) inhibiting the extracellular signal regulated kinase-induced human airway smooth muscle proliferation in asthma

Effect of Shenmai Injection (参麦注射液) on ventricular diastolic function in patients with chronic heart failure: An assessment by tissue Doppler imaging

Reperfusion therapy in integrative medicine: the most basic treatment for preventing ventricular remodeling in post-myocardial infarction patients

Change of Th1/Th2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection

Clinical study on effect of Shenmai Injection in treating congestive heart failure

Related Author

No data

Related Institution

Department of Respiratory Diseases, Henan Province People’s Hospital

Department of Internal Medicine, The Second People’s Hospital of Yuhang District

. for Research on the Theory of Qi-Blood of Integrated Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Beijing

Ministry of Education

Lab. of Chinese Internal Medicine, Beijing University of Chinese Medicine, Beijing

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰